AccessPak for HIV PEP Expanded with Kaletra and Rifamycin Sodium
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Rifamycin Sodium and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: rifamycin
Brand name: Aemcolo
Synonyms: Rifamycin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Rifapentine
- AccessPak for HIV PEP Expanded with Kaletra-Rifater
- AccessPak for HIV PEP Expanded with Kaletra-Rifaximin
- AccessPak for HIV PEP Expanded with Kaletra-Rilonacept
- AccessPak for HIV PEP Expanded with Kaletra-Rilonacept Subcutaneous
- AccessPak for HIV PEP Expanded with Kaletra-Rilpivirine
- Rifamycin Sodium-AccessPak for HIV PEP Expanded with Viracept
- Rifamycin Sodium-Accolate
- Rifamycin Sodium-Accretropin
- Rifamycin Sodium-Accucaine
- Rifamycin Sodium-AccuHist Drops
- Rifamycin Sodium-AccuHist PDX Drops